US equities
|
INTC
$63.61
▼-30.91%
NVDA
$201.70
▼-5.60%
AMZN
$237.81
▼-2.45%
MU
$865.76
▼-7.33%
SNDK
$1,125.30
▼-15.39%
GOOGL
$277.88
▼-2.09%
AMD
$495.13
▼-12.59%
AAPL
$343.35
▼-1.59%
INTC
$63.61
▼-30.91%
NVDA
$201.70
▼-5.60%
AMZN
$237.81
▼-2.45%
MU
$865.76
▼-7.33%
SNDK
$1,125.30
▼-15.39%
GOOGL
$277.88
▼-2.09%
AMD
$495.13
▼-12.59%
AAPL
$343.35
▼-1.59%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about Christopher J/ Burns
Recent news which mentions Christopher J/ Burns
Lab Notes: Venatorx closes Series C financing; Ocugen takes 'critical' step in clinical trial
April 08, 2022
Tickers
INNO
Tags
Jim Moran
Medical Devices
Christopher J/ Burns
From
Business Journals
Venatorx and Roche team up to take on 'superbugs' with new class of antibiotics
November 01, 2021
Tags
Christopher J/ Burns
Health Care
Biotech
From
Business Journals